Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.-Reference-Cited by-同舟云学术

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

Published:2019-10-08 Issue:6 Volume:6 Page:1199-1207
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Bouabdallaoui Nadia¹^ORCID,O'Meara Eileen¹,Bernier Virginie²,Komajda Michel³,Swedberg Karl⁴⁵,Tavazzi Luigi⁶,Borer Jeffrey S.⁷,Bohm Michael⁸,Ford Ian⁹,Tardif Jean‐Claude¹

Affiliation:

1. Montreal Heart InstituteUniversité de Montréal 5000 Belanger Street Montreal H1T 1C8 Quebec Canada

2. Scientific and Medical AffairsServier Canada Inc. Laval Quebec Canada

3. Department of CardiologyParis Saint Joseph Hospital Paris France

4. Department of Molecular and Clinical MedicineSahlgrenska Academy, University of Gothenburg Gothenburg Sweden

5. National Heart and Lung InstituteImperial College London London UK

6. Maria Cecilia Hospital, GVM Care & Research Cotignola Italy

7. Howard Gilman and Schiavone InstitutesState University of New York Downstate Medical Center New York NY USA

8. Internal Medicine Clinic III, Saarland University ClinicSaarland University Homburg Saar Germany

9. Robertson Centre for BiostatisticsUniversity of Glasgow Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12513

Reference35 articles.

1. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

2. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

5. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol;ESC Heart Failure;2023-11-14

2. Cardiac reverse remodelling by imaging parameters with recent changes to guideline medical therapy in heart failure;ESC Heart Failure;2023-10-23

3. Ivabradine in patients with heart failure: a systematic literature review;Journal of Market Access & Health Policy;2023-10-04

4. Therapeutic Use and Molecular Aspects of Ivabradine in Cardiac Remodeling: A Review;International Journal of Molecular Sciences;2023-02-01

5. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations;Open Heart;2022-10